Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026)
Jushi Holdings (JUSHF) reported Amortization of Deferred Charges of $2.6 million for Q1 2026, up 19.24% year-over-year from $2.2 million in Q1 2025, and down 0.58% quarter-over-quarter from $2.6 million in Q4 2025.
Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Amortization of Deferred Charges data on file, last reported at $2.6 million in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $2.6 million, up 19.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 million (up 32.57% YoY), and the FY2025 annual result was $9.8 million, up 39.4% from the prior year.
- Amortization of Deferred Charges fell to $2.6 million in Q1 2026 per JUSHF's latest filing, from $2.6 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $5.9 million in Q2 2022 and troughed at $1.2 million in Q2 2023.
- A 5-year average of $2.7 million and a median of $2.2 million in 2025 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges sank 79.8% in 2023, then surged 52.96% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $3.8 million in 2022, then sank by 50.63% to $1.9 million in 2023, then increased by 4.59% to $2.0 million in 2024, then jumped by 31.48% to $2.6 million in 2025, then retreated by 0.58% to $2.6 million in 2026.
- Business Quant data shows JUSHF's Amortization of Deferred Charges at $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |